| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 10/12/2006 | CA2602467A1 Bcrp/abcg2 inhibitor |
| 10/11/2006 | EP1710240A1 Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists |
| 10/11/2006 | EP1710238A1 Benzophenones as inhibitors of reverse transcriptase |
| 10/11/2006 | EP1710236A1 Derivatives of pyridine and quinoline |
| 10/11/2006 | EP1709027A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 10/11/2006 | EP1709002A2 Montelukast sodium polymorphs |
| 10/11/2006 | EP1709001A2 Solid forms of montelukast acid |
| 10/11/2006 | EP1708994A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 10/11/2006 | EP1708708A1 Montelukast free acid polymorphs |
| 10/11/2006 | EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 10/11/2006 | EP1107959B1 Quinazoline derivatives as medicaments |
| 10/11/2006 | EP0944619B1 Novel integrin receptor antagonists |
| 10/11/2006 | CN1845933A Specific glucocorticosteriod compound having anti-inflamatory activity |
| 10/11/2006 | CN1845921A Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPP-IV inhibitors |
| 10/11/2006 | CN1845900A Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 10/11/2006 | CN1845899A Process for producing high purity 3,5-dihydroxy-6-heptenoic acid derivative |
| 10/11/2006 | CN1845740A Piperazine derivatives for the treatment of HIV infections |
| 10/11/2006 | CN1844101A Process for preparing 2-aryl quinoline derivatives |
| 10/10/2006 | US7119120 A 2-benzenesulfonylamino-N-benzyl-benzamides for treating hyperphosphatemia, urogential disorders |
| 10/10/2006 | US7119080 Boronic ester and acid compounds, synthesis and uses |
| 10/10/2006 | US7118899 Introducing a reagent comprising a hydrophobic fluorescent ion; measuring energy transfer |
| 10/10/2006 | US7118730 Quinoline derivative as diagnostic probe for disease with tau protein accumulation |
| 10/05/2006 | WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors |
| 10/05/2006 | WO2006103511A1 Cyclopentapyridine and tetrahydroquinoline derivatives |
| 10/05/2006 | WO2006102760A1 Inhibitors of histone deacetylase |
| 10/05/2006 | WO2006071609A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 10/05/2006 | WO2006059245A3 Compounds for the treatment of cns and amyloid associated diseases |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | US20060223999 Process for preparing montelukast and precursors thereof |
| 10/05/2006 | US20060223854 For therapy of thromboembolic and/or inflammatory disorders |
| 10/05/2006 | US20060223853 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 10/05/2006 | US20060223851 Triamide-substituted heterobicyclic compounds |
| 10/05/2006 | US20060223850 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors |
| 10/05/2006 | US20060223819 Quinoline Derivatives as NK-3 Antagonists |
| 10/05/2006 | CA2603589A1 Inhibitors of histone deacetylase |
| 10/05/2006 | CA2603345A1 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 10/04/2006 | EP1706384A1 Therapeutic agents i |
| 10/04/2006 | EP1706383A1 Amine salt of carbostyril derivative |
| 10/04/2006 | EP1706371A1 Aryl aniline derivatives as beta2 adrenergic receptor agonists |
| 10/04/2006 | EP0906091B1 Amidinohydrazones as protease inhibitors |
| 10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/03/2006 | US7115750 Melanin concentrating hormone antagonist |
| 10/03/2006 | US7115745 Benzyl urea and thiourea derivatives |
| 10/03/2006 | US7115744 Method for producing 8-methoxy-quinolinecarboxylic acids |
| 10/03/2006 | US7115661 Methods and compositions for mitigating pain |
| 10/03/2006 | US7115630 Metabotropic glutamate receptor antagonists |
| 10/03/2006 | US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 10/03/2006 | US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties |
| 10/03/2006 | US7115607 Substituted piperazinyl amides and methods of use |
| 10/03/2006 | US7115605 Peptide deformylase inhibitors |
| 10/03/2006 | US7115600 Histamine-3 receptor modulators |
| 10/03/2006 | US7115541 Catalyst comprising n-substituted cyclic imides and processes for preparing organic compounds with the catalyst |
| 10/03/2006 | US7115401 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential |
| 10/03/2006 | CA2231633C Process for the preparation of anti-malarial drugs |
| 10/03/2006 | CA2151507C Pharmaceutical composition containing bicyclic type compounds |
| 09/28/2006 | WO2006100100A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 09/28/2006 | WO2006100099A1 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents |
| 09/28/2006 | WO2006079719A3 Novel heterocyclic oxime derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/28/2006 | WO2006064269A3 Salts of leukotriene antagonist montelukast |
| 09/28/2006 | WO2006055725A3 Substituted amino acids as protein tyrosine phosphatase inhibitors |
| 09/28/2006 | US20060217433 Sulfonamide derivatives as ppar modulators |
| 09/28/2006 | US20060217413 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 09/28/2006 | US20060217403 Substituted 2-aminoacetamides and the use thereof |
| 09/28/2006 | US20060217399 Phenyl quinolines and their use as estrogenic agents |
| 09/28/2006 | DE202005020539U1 Aripiprazol Aripiprazole |
| 09/28/2006 | DE10321255B4 Verfahren zur Herstellung von reinstem rac-1{4-[2- Hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2-diphenylethan-1-one fumarat und reinstes rac-1{4-[2-Hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2 A process for producing the purest rac-1 {4- [2- hydroxy-3- (5-quinolyloxy) propyl] -piperazin-1-yl} -2,2-diphenylethan-1-one fumarate and the purest rac-1 {4 - [2-hydroxy-3- (5-quinolyloxy) propyl] -piperazin-1-yl} -2,2 |
| 09/28/2006 | DE102005014089A1 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories |
| 09/28/2006 | CA2598969A1 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents |
| 09/28/2006 | CA2598205A1 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 09/27/2006 | EP1705174A1 Selective androgen receptor modulators and methods of use thereof |
| 09/27/2006 | EP1704139A1 DISUBSTITUTED CHALCONE OXIMES AS SELECTIVE AGONISTS OF RAR y RETINOID RECEPTORS |
| 09/27/2006 | CN1839121A Hydroxamic acid compounds and methods of use thereof |
| 09/27/2006 | CN1838956A 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds |
| 09/26/2006 | US7112677 1H-imidazo dimers |
| 09/21/2006 | WO2006099410A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 09/21/2006 | WO2006098912A1 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 09/21/2006 | WO2006098394A1 Method for inhibiting lipid absorption and lipid absorption inhibitor |
| 09/21/2006 | WO2006098308A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | WO2006097488A1 Use of n- (4-pyridyl) methylsulfonamides for combating arthropodal pests |
| 09/21/2006 | WO2006097343A1 Process of making crystalline type ii aripiprazole |
| 09/21/2006 | WO2006067587A3 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 09/21/2006 | WO2006063294A3 Novel inhibitors of histone deacetylase for the treatment of disease |
| 09/21/2006 | WO2006002421A3 Modulators of atp-binding cassette transporters |
| 09/21/2006 | WO2005037207A3 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 09/21/2006 | US20060211860 Compounds for the treatment of Alzheimer's disease |
| 09/21/2006 | US20060211727 Novel compounds |
| 09/21/2006 | US20060211717 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/21/2006 | US20060211707 Piperazine-alkyl-ureido derivatives |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211689 Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 09/21/2006 | US20060211680 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 09/21/2006 | US20060211677 5-lipoxygenase activating protein inhibitors; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents |
| 09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
| 09/21/2006 | CA2602609A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | CA2600860A1 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 09/21/2006 | CA2600541A1 Process of making crystalline type ii aripiprazole |
| 09/21/2006 | CA2599551A1 Use of n- (4-pyridyl) methylsulfonamides for combating arthropodal pests |
| 09/20/2006 | EP1701946A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/20/2006 | EP1701943A1 5-ht2 receptors modulators, their pharmaceutical compositions and their use for the treatment of cardiovascular and muscle diseases |
| 09/20/2006 | EP1701934A2 DISUBSTITUTED CHALCONE OXIMES HAVING RAR(Gamma)-RETINOID RECEPTOR ANTAGONIST ACTIVITY |